CMMEL22099_Galka_S2015
Basic Study Information
Purpose:
Patients with a primary invasive melanoma are recommended to undergo excision of the
primary lesion with a wide margin. There is evidence that less radical margins of
excision may be just as safe. This is a randomised controlled trial of 1 cm versus
2 cm margin of excision of the primary lesion for adult patients with stage II primary
invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free
survival. A reduction in margins is expected to improve patient quality of life.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Eva Galka
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search